DUBLIN, Sept. 26, 2019 /PRNewswire/ -- The "Skin Replacement and Substitutes Market Research Report: By Product, Class, Application, End-User, Regional Insight - Global Industry Analysis and Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
From $838.0 million in 2018, the market is predicted to grow to $1,202.2 million by 2024, advancing at a 6.3% CAGR during the forecast period (2019-2024).
The rising skin disease prevalence, increasing incidence of burns, and growing awareness about appearances are the major drivers of the skin replacement and substitutes market. Skin grafts, which are taken from a suitable donor by separating them from the tissue bed and transplanted into the recipient's affected area, are known as skin replacement substitutes.
A major driving factor for the skin replacement and substitutes market is the increasing prevalence of dermatological conditions. A 2017 report published by the American Academy of Dermatology mentioned that one in three Americans were suspected to suffer from some dermatological condition that year. The rising prevalence of skin diseases can be attributed to the increasing exposure to X-rays, ultraviolet rays, and infrared waves. Further, the World Health Organization (WHO) reported that about 900 million people in the world are affected by skin diseases, necessitating the use for such products.
Another major influencer of the skin replacement and substitutes market advance is the surging number of burn cases. A report published by the WHO revealed that of the approximately 180,000 global deaths due to burn injuries every year, the majority occur in low and middle-income countries. Further, many children suffering from burns become disabled due to the severity of the condition and improper medical care in countries such as Egypt, Bangladesh, Pakistan, and Colombia. To treat burn wounds, skin replacement and substitute products are of great help.
Based on geography, the skin replacement and substitutes market is divided into middle East & Africa, North America, Latin America, Asia-Pacific (APAC), and Europe. Throughout the historical period (2014-2018), the highest demand for these products was witnessed in North America.
The region is expected to generate 56.8% revenue in 2024 due to a large number of wound care hospitals and clinics. The fastest growth in the forecast period is expected to be witnessed by the APAC region due to the improving healthcare facilities as well as rising number of burn cases.
Key Topics Covered:
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.2 By Class
184.108.40.206 Class III
220.127.116.11 Class II
18.104.22.168.1 Cultured epithelial autograft
22.214.171.124.2 Acellular dermal matrix
126.96.36.199.3 Collagen scaffolds
188.8.131.52 Class I
184.108.40.206.1 Amniotic membrane
220.127.116.11.2 Synthetic skin
4.1.3 By Application
18.104.22.168 Cosmetic surgery
4.1.4 By End User
22.214.171.124 Wound care clinics & hospitals
126.96.36.199 Beauty & cosmetics industry
4.2 Market Dynamics
188.8.131.52 Increasing cases of burns
184.108.40.206 Rising inclination of the consumers to spend on appearance
220.127.116.11 Rising incidence of skin diseases
18.104.22.168 Impact analysis of drivers on market forecast
22.214.171.124 Availability of low-cost substitutes
126.96.36.199 Side-effects associated with skin replacement procedures
188.8.131.52 Lack of skilled professionals
184.108.40.206 Impact analysis of restraints on market forecast
220.127.116.11 Increasing need of bio-engineered skin replacement
4.3 Porter's Five Forces Analysis
4.4 Regulatory Framework Analysis
4.4.1 European Commission
4.4.2 U.S. Food and Drug Administration (FDA)
4.5 Pipeline Products
4.6 Reimbursement Policies
4.7 Limitations of Skin Substitutes
4.8 Future Prospects of Skin Substitutes and Replacement
4.9 Applications of Skin Substitutes
Chapter 5. Global Market Size and Forecast
5.1 By Product
5.2 By Class
5.2.1 Class III Skin Replacement and Substitutes Market, by Type
5.2.2 Class II Skin Replacement and Substitutes Market, by Type
5.2.3 Class I Skin Replacement and Substitutes Market, by Type
5.3 By Application
5.4 By End User
5.5 By Region
Chapter 6. North America Market Size and Forecast
Chapter 7. Europe Market Size and Forecast
Chapter 8. APAC
Chapter 9. LATAM Market Size and Forecast
Chapter 10. MEA
Chapter 11. Competitive Landscape
11.1 Competitive Benchmarking
11.2 Strategic Developments
11.2.1 Acquisitions and Collaborations
11.2.2 Product Launches
Chapter 12. Company Profiles
- Acelity L.P. Inc.
- MiMedx Group Inc.
- Organogenesis Inc.
- Vericel Corporation
- FUJIFILM Cellular Dynamics Inc.
- Smith & Nephew plc
- Integra LifeSciences Holdings Corporation
- MatTek Corporation
For more information about this report visit https://www.researchandmarkets.com/r/4gxxjl
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets